Top compounds associated with response to KCNE5


Feature Type Standardized
Nominal ANOVA
mRNA quizartinib CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.19 1e-08
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-08
mRNA ATRA GDSC1000 pan-cancer AAC 0.18 5e-08
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.17 6e-08
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.18 7e-08
mRNA staurosporine CTRPv2 pan-cancer AAC 0.35 1e-07
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.18 1e-07
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.23 1e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-07
Download CSV